+44 115 7870500
DevelRx Logo
HomeTeam
Services
Research & Candidate SelectionDrug DevelopmentRegistrationMarketing
News & EventsPartnersContact

Poster presentations - Psychiatric and Neurological Disorders

Drug Abuse and DependenceADHDBinge-Eating DisorderPsychiatric and Neurological DisordersObesity and Metabolic Disorders

Eyerman DJ, Rowley HL, Jacobi I, Cunningham JI, Heal DJ, Dean RL, Deaver DR. Combinations of buprenorphine and samidorphan modulate glutamatergic transmission in the medial prefrontal cortex and ventral hippocampus of male Wistar rats. American College of Neuropsychopharmacology Meeting, Dec 2014.

Hutson P, Rowley HL, Kulkarni RS, Heal DJ. Investigating the interaction between lisdexamfetamine and S-citalopram on monoamine neurochemistry by dual-probe microdialysis in freely moving rats – Evidence for synergistic augmentation of serotonin and dopamine efflux. American Academy of Child and Adolescent Psychiatry Congress, Oct 2014.

Hutson PH, Rowley HL, Kulkarni RS, Heal DJ. Determination of the monoaminergic interactions between lisdexamfetamine dimesylate (LDX) and duloxetine reveals a synergistic augmentation of dopamine efflux in the nucleus accumbens and striatum. New Clinical Drug Evaluation Unit (NCDEU) Meeting, June 2014.

Jackson HC, Rowley HL, Hackett D, Heal D. A microdialysis and behavioral comparison of lisdexamfetamine and methylphenidate in freely-moving rats. Society for Neurosciences Congress, Nov 2012.

Cheetham SC, Sood P, Prow MR, Rowley HL, Heal DJ. Profound suppression of noradrenaline, dopamine and 5-HT turnover in various regions of rat brain evoked by the α2-adrenoceptor agonist, clonidine. Society for Neurosciences Congress, Nov 2012.

DevelRx Logo

Biocity,

Pennyfoot Street,

Nottingham,

Nottinghamshire,

NG1 1GF

Legal

Cookie PolicyPrivacy PolicyTerms & Conditions
inform@develrx.com

Registered in England and Wales

Company number: 12028847